Fabio Luiz Navarro Marques

Dr. Fabio Luiz Navarro Marques

orcid

Research Focus & Metrics

Academic Career Length

26Years (2001-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 August 2010 in PLOS ONE
Verified
Journal Article
Open access
PDF file
MDMaria E. Danoviz
Maria E. Danoviz
JNJuliana S. Nakamuta
Juliana S. Nakamuta
Fabio Luiz Navarro MarquesFabio Luiz Navarro Marques
Fabio Luiz Navarro Marques
LSLeonardo dos Santos
Leonardo dos Santos
EAErika Costa de Alvarenga
Erika Costa de Alvarenga
JKJose Krieger
Jose Krieger
Cardiac cell transplantation is compromised by low cell retention and poor graft viability. Here, the effects of co-injecting adipose tissue-derived stem cells (ASCs) with biopolymers on cell cardiac retention, ventricular morphometry and performance were evaluated in a rat model of myocardial infarction (MI). 99mTc-labeled ASCs (1×106 cells) isolated from isogenic Lewis rats were injected 24 hours post-MI using fibrin a, collagen (ASC/C), or culture medium (ASC/M) as vehicle, and cell body distribution was assessed 24 hours later by γ-emission counting of harvested organs. ASC/F and ASC/C groups retained significantly more cells in the myocardium than ASC/M (13.8±2.0 and 26.8±2.4% vs. 4.8±0.7%, respectively). Then, morphometric and direct cardiac functional parameters were evaluated 4 weeks post-MI cell injection. Left ventricle (LV) perimeter and percentage of interstitial collagen in the spare myocardium were significantly attenuated in all ASC-treated groups compared to the non-treated (NT) and control groups (culture medium, fibrin, or collagen alone). Direct hemodynamic assessment under pharmacological stress showed that stroke volume (SV) and left ventricle end-diastolic pressure were preserved in ASC-treated groups regardless of the vehicle used to deliver ASCs. Stroke work (SW), a global index of cardiac function, improved in ASC/M while it normalized when biopolymers were co-injected with ASCs. A positive correlation was observed between cardiac ASCs retention and preservation of SV and improvement in SW post-MI under hemodynamic stress. We provided direct evidence that intramyocardial injection of ASCs mitigates the negative cardiac remodeling and preserves ventricular function post-MI in rats and these beneficial effects can be further enhanced by administrating co-injection of ASCs with biopolymers.

23 June 2009 in PLOS ONE
Verified
Journal Article
Open access
PDF file
JNJuliana S. Nakamuta
Juliana S. Nakamuta
MDMaria E. Danoviz
Maria E. Danoviz
Fabio Luiz Navarro MarquesFabio Luiz Navarro Marques
Fabio Luiz Navarro Marques
LSLeonardo dos Santos
Leonardo dos Santos
CBClaudia Becker
Claudia Becker
JKJose Krieger
Jose Krieger
Cell therapy approaches for biologic cardiac repair hold great promises, although basic fundamental issues remain poorly understood. In the present study we examined the effects of timing and routes of administration of bone marrow cells (BMC) post-myocardial infarction (MI) and the efficacy of an injectable biopolymer scaffold to improve cardiac cell retention and function. 99mTc-labeled BMC (6×106 cells) were injected by 4 different routes in adult rats: intravenous (IV), left ventricular cavity (LV), left ventricular cavity with temporal aorta occlusion (LV+) to mimic coronary injection, and intramyocardial (IM). The injections were performed 1, 2, 3, or 7 days post-MI and cell retention was estimated by γ-emission counting of the organs excised 24 hs after cell injection. IM injection improved cell retention and attenuated cardiac dysfunction, whereas IV, LV or LV* routes were somewhat inefficient (<1%). Cardiac BMC retention was not influenced by timing except for the IM injection that showed greater cell retention at 7 (16%) vs. 1, 2 or 3 (average of 7%) days post-MI. Cardiac cell retention was further improved by an injectable fibrin scaffold at day 3 post-MI (17 vs. 7%), even though morphometric and function parameters evaluated 4 weeks later displayed similar improvements. These results show that cells injected post-MI display comparable tissue distribution profile regardless of the route of injection and that there is no time effect for cardiac cell accumulation for injections performed 1 to 3 days post-MI. As expected the IM injection is the most efficient for cardiac cell retention, it can be further improved by co-injection with a fibrin scaffold and it significantly attenuates cardiac dysfunction evaluated 4 weeks post myocardial infarction. These pharmacokinetic data obtained under similar experimental conditions are essential for further development of these novel approaches.

16 December 2020 in Nanoscale
Verified
Journal Article
Open access
PDF file
ABArthur Berger
Arthur Berger
IAIrami Araújo-Filho
Irami Araújo-Filho
MPMax Piffoux
Max Piffoux
ANAlba Nicolas-Boluda
Alba Nicolas-Boluda
AGAlice Grangier
Alice Grangier
ASAmanda K. A. Silva
Amanda K. A. Silva
Extracellular vesicles (EVs), especially from stem/stromal cells (SCs), represent a cell-free alternative in regenerative medicine holding promises to promote tissue healing while providing safety and logistic advantages in comparison to cellular counterparts. Herein, we hypothesize that SC EVs, administered locally in a thermoresponsive gel, is a therapeutic strategy for managing post-surgical colo-cutaneous fistulas. This disease is a neglected and challenging condition associated to low remission rates and high refractoriness. Herein, EVs from a murine SC line were produced by a high-yield scalable method in bioreactors. The post-surgical intestinal fistula model was induced via a surgical cecostomy communicating the cecum and the skin in Wistar rats. Animals were treated just after cecostomy with PBS, thermoresponsive Pluronic F-127 hydrogel alone or containing SC EVs. A PET-monitored biodistribution investigation of SC EVs labelled with 89Zr was performed. Fistula external orifice and output assessment, probe-based confocal laser endomicroscopy, MRI and histology were carried out for therapy follow-up. The relevance of percutaneous EV administration embedded in the hydrogel vehicle was indicated by the PET-biodistribution study. Local administration of SC EVs in the hydrogel reduced colo-cutaneous fistula diameter, output, fibrosis and inflammation while increasing the density of neo-vessels when compared to the PBS and gel groups. This multi-modal investigation pointed-out the therapeutic potential of SC EVs administered locally and in a thermoresponsive hydrogel for the management of challenging post-surgical colon fistulas in a minimally-invasive cell-free strategy.

3 December 2015 in Cancer Letters
Verified
Journal Article
Closed access
PDF file
RARodrigo Aguiar
Rodrigo Aguiar
CPCarolina Bellini Parise
Carolina Bellini Parise
CSCarolina Rosal Teixeira Souza
Carolina Rosal Teixeira Souza
CBCamila Braggion
Camila Braggion
WQWagner Quintilio
Wagner Quintilio
JMJane Zveiter de Moraes
Jane Zveiter de Moraes

1 October 2012 in Biomedicine & Pharmacotherapy
Verified
Journal Article
Closed access
AFAdilson Kleber Ferreira
Adilson Kleber Ferreira
RMRenato Meneguelo
Renato Meneguelo
Fabio Luiz Navarro MarquesFabio Luiz Navarro Marques
Fabio Luiz Navarro Marques
ARAdriano Radin
Adriano Radin
OFOtaviano Mendonça R. Filho
Otaviano Mendonça R. Filho
DMDurvanei Augusto Maria
Durvanei Augusto Maria

28 August 2008 in Veterinary Radiology & Ultrasound
Verified
Journal Article
Closed access
PDF file
CPCamila Trevisan Pereira
Camila Trevisan Pereira
Fabio Luiz Navarro MarquesFabio Luiz Navarro Marques
Fabio Luiz Navarro Marques
JWJamie Williams
Jamie Williams
BMBenedicto Wlademir DE Martin
Benedicto Wlademir DE Martin
PBPedro Primo Bombonato
Pedro Primo Bombonato